Turn Therapeutics Inc. TTRX

Rank #2509 · Nasdaq · $0.3B market cap

⚠ Going-concern flag — the auditor (WithumSmith+Brown, PC) raised substantial doubt about this company's ability to continue operating in the latest filing. Read the actual filing before drawing conclusions.

Score

11.0

P/E

-175.7

P/B

3622.44

ROE

-2061.9%

Op. Margin

–%

Debt Ratio

2596%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★☆☆☆☆

Poor

P/E -175.7x, P/B 3622.44x. Ranks in the top 82% of the universe.

Profitability ★☆☆☆☆

Poor

ROE -2061.9%. Ranks in the top 100% of the universe.

Safety ★☆☆☆☆

Poor

Debt ratio 2596%. Ranks in the top 98% of the universe. Above 200% signals meaningful leverage risk.

Growth –

No data

Not enough historical filings to compute year-over-year growth yet.

Valuation is the relative strength (relative to this universe).

Financials annual, from SEC 10-K filings

FY	Revenue	Op. Income	Net Income	Equity	Op. Margin%	Debt%
2025	–	$-0.0B	$-0.0B	$0.0B	–	2596

← See the full screener